Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcelo Pasquini

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
Journal for Immunotherapy of Cancer|February 9, 2025
Real-world outcomes with tisagenlecleucel in aggressive B-cell lymphoma: subgroup analyses from the CIBMTR registryDaniel J Landsburg, Matthew J Frigault, Michael Heim, et al.
Leukemia|July 27, 2021
Decrease post-transplant relapse using donor-derived expanded NK-cellsStefan O Ciurea, Piyanuch Kongtim, Doris Soebbing, et al.
Transplantation and Cellular Therapy|June 10, 2026
Neighborhood socioeconomic disadvantage and distance from treatment center do not impact survival outcomes of patients with non-Hodgkin lymphoma and multiple myeloma treated with CAR T-cell therapiesAgrima Mian, Rafaella Litvin, Danai Dima, et al.
Blood|April 4, 2018
Exome chip analyses identify genes affecting mortality after HLA-matched unrelated-donor blood and marrow transplantationQianqian Zhu, Li Yan, Qian Liu, et al.
Cytotherapy|February 27, 2022
Need for aligning the definition and reporting of cytokine release syndrome (CRS) in immuno-oncology clinical trialsMark D Stewart, Bruce McCall, Marcelo Pasquini, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 16, 2019
Association of Antiepileptic Medications with Outcomes after Allogeneic Hematopoietic Cell Transplantation with Busulfan/Cyclophosphamide ConditioningJeannine S McCune, Tao Wang, Khalid Bo-Subait, et al.
Blood Advances|October 21, 2021
Allogeneic transplant and CAR-T therapy after autologous transplant failure in DLBCL: a noncomparative cohort analysisMehdi Hamadani, Ajay K Gopal, Marcelo Pasquini, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 14, 2015
A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortalityMargaret L MacMillan, Marie Robin, Andrew C Harris, et al.
Blood|September 27, 2021
Autologous transplant vs chimeric antigen receptor T-cell therapy for relapsed DLBCL in partial remissionMazyar Shadman, Marcelo Pasquini, Kwang Woo Ahn, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 15, 2016
Graft-versus-Host Disease after HLA-Matched Sibling Bone Marrow or Peripheral Blood Stem Cell Transplantation: Comparison of North American Caucasian and Japanese PopulationsJunya Kanda, Ruta Brazauskas, Zhen-Huan Hu, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Journal for Immunotherapy of Cancer|February 9, 2025
Real-world outcomes with tisagenlecleucel in aggressive B-cell lymphoma: subgroup analyses from the CIBMTR registryDaniel J Landsburg, Matthew J Frigault, Michael Heim, et al.
Leukemia|July 27, 2021
Decrease post-transplant relapse using donor-derived expanded NK-cellsStefan O Ciurea, Piyanuch Kongtim, Doris Soebbing, et al.
Transplantation and Cellular Therapy|June 10, 2026
Neighborhood socioeconomic disadvantage and distance from treatment center do not impact survival outcomes of patients with non-Hodgkin lymphoma and multiple myeloma treated with CAR T-cell therapiesAgrima Mian, Rafaella Litvin, Danai Dima, et al.
Blood|April 4, 2018
Exome chip analyses identify genes affecting mortality after HLA-matched unrelated-donor blood and marrow transplantationQianqian Zhu, Li Yan, Qian Liu, et al.
Cytotherapy|February 27, 2022
Need for aligning the definition and reporting of cytokine release syndrome (CRS) in immuno-oncology clinical trialsMark D Stewart, Bruce McCall, Marcelo Pasquini, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 16, 2019
Association of Antiepileptic Medications with Outcomes after Allogeneic Hematopoietic Cell Transplantation with Busulfan/Cyclophosphamide ConditioningJeannine S McCune, Tao Wang, Khalid Bo-Subait, et al.
Blood Advances|October 21, 2021
Allogeneic transplant and CAR-T therapy after autologous transplant failure in DLBCL: a noncomparative cohort analysisMehdi Hamadani, Ajay K Gopal, Marcelo Pasquini, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 14, 2015
A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortalityMargaret L MacMillan, Marie Robin, Andrew C Harris, et al.
Blood|September 27, 2021
Autologous transplant vs chimeric antigen receptor T-cell therapy for relapsed DLBCL in partial remissionMazyar Shadman, Marcelo Pasquini, Kwang Woo Ahn, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 15, 2016
Graft-versus-Host Disease after HLA-Matched Sibling Bone Marrow or Peripheral Blood Stem Cell Transplantation: Comparison of North American Caucasian and Japanese PopulationsJunya Kanda, Ruta Brazauskas, Zhen-Huan Hu, et al.
Pageof 9